Related Experiment Video
Updated: Oct 19, 2025
Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
Published on: May 14, 2019
Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies
Andrew Cannon1, Christopher M Thompson1, Rakesh Bhatia1
1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, United States of America.
Abstract:
Metastasis is a significant cause of the mortality resulting from solid malignancies. The process of metastasis is complex and is regulated by numerous cancer cell-intrinsic and -extrinsic factors. CXCR3 is a chemokine receptor that is frequently expressed by cancer cells, endothelial cells and immune cells. CXCR3A signaling in cancer cells tends to promote the invasive and migratory phenotype of cancer cells. Indirectly, CXCR3 modulates the anti-tumor immune response resulting in variable effects that can permit or inhibit metastatic progression. Finally, the activity of CXCR3B in endothelial cells is generally angiostatic, which limits the access of cancer cells to key conduits to secondary sites. However, the interaction of these activities within a tumor and the presence of opposing CXCR3 splice variants clouds the picture of the role of CXCR3 in metastasis. Consequently, thorough analysis of the contributions of CXCR3 to cancer metastasis is necessary. This review is an in-depth examination of the involvement of CXCR3 in the metastatic process of solid malignancies.
Insights
The chemokine receptor CXCR3 has complex roles in cancer metastasis, promoting invasion via cancer cell signaling but also influencing anti-tumor immunity and blood vessel formation. Understanding these dual roles is crucial for developing effective cancer treatments.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Metastasis is a primary cause of cancer mortality.
- Cancer metastasis is a complex process influenced by intrinsic and extrinsic factors.
- CXCR3 chemokine receptor is expressed on cancer cells, endothelial cells, and immune cells.
Purpose of the Study:
- To examine the multifaceted role of CXCR3 in solid tumor metastasis.
- To elucidate how CXCR3 splice variants (CXCR3A and CXCR3B) influence metastatic processes.
- To analyze the impact of CXCR3 on cancer cell invasion, migration, and anti-tumor immunity.
Main Methods:
- Literature review and synthesis of existing research on CXCR3 and metastasis.
- Analysis of CXCR3 signaling pathways in cancer cells and endothelial cells.
- Examination of CXCR3's modulation of the tumor microenvironment and immune response.
Main Results:
- CXCR3A signaling in cancer cells promotes invasion and migration.
- CXCR3 influences anti-tumor immunity with variable effects on metastasis.
- CXCR3B signaling in endothelial cells exhibits angiostatic effects, potentially limiting metastasis.
Conclusions:
- The role of CXCR3 in metastasis is complex due to opposing splice variant activities.
- Further research is needed to fully understand CXCR3's contribution to cancer metastasis.
- Targeting CXCR3 pathways may offer novel therapeutic strategies for solid malignancies.
Related Concept Videos
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:41Non-Canonical Wnt Signaling Pathways
02:54Canonical Wnt Signaling Pathway
02:38Mitogens and the Cell Cycle
01:21Chemotaxis and Direction of Cell Migration
02:17The Tumor Microenvironment